New England Research & Management, Inc. Amgen Inc Transaction History

New England Research & Management, Inc.

$213 Million
Q3 2024

A detailed history of New England Research & Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, New England Research & Management, Inc. holds 10,574 shares of AMGN stock, worth $2.78 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares

10,574

Previous 8,064 31.13%

Holding current value

$2.78 Million

Previous $2.52 Million 35.2%

% of portfolio

1.6%

Previous 1.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $776,543 - $846,823	2,510 Added 31.13%	10,574 $3.41 Million
Q2 2024 Jul 09, 2024	SELL	$262.75 - $319.31 $233,584 - $283,866	-889 Reduced 9.93%	8,064 $2.52 Million
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $847,747 - $1.02 Million	3,153 Added 54.36%	8,953 $2.55 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $1.06 Million - $1.2 Million	-4,160 Reduced 41.77%	5,800 $1.67 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $933,635 - $1.16 Million	-4,270 Reduced 30.01%	9,960 $2.68 Million
Q2 2023 Jul 05, 2023	BUY	$214.27 - $253.37 $894,577 - $1.06 Million	4,175 Added 41.52%	14,230 $3.16 Million
Q1 2023 Apr 06, 2023	BUY	$225.79 - $275.2 $1.08 Million - $1.31 Million	4,775 Added 90.44%	10,055 $2.43 Million
Q4 2022 Jan 09, 2023	BUY	$229.03 - $291.01 $1.21 Million - $1.54 Million	5,280 New	5,280 $1.39 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $613,688 - $682,928	-2,660 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $21,927 - $24,257	-100 Reduced 3.62%	2,660 $643,000
Q4 2021 Jan 05, 2022	SELL	$198.88 - $227.6 $66,624 - $76,246	-335 Reduced 10.82%	2,760 $621,000
Q3 2021 Oct 08, 2021	SELL	$212.27 - $248.7 $759,926 - $890,346	-3,580 Reduced 53.63%	3,095 $658,000
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $1.56 Million - $1.73 Million	6,675 New	6,675 $1.63 Million
Q4 2020 Jan 07, 2021	SELL	$216.38 - $257.67 $302,932 - $360,738	-1,400 Closed	0 $0
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $546,499 - $607,752	-2,329 Reduced 62.46%	1,400 $356,000
Q2 2020 Jul 15, 2020	BUY	$197.81 - $242.74 $445,072 - $546,165	2,250 Added 152.13%	3,729 $880,000
Q1 2020 Jun 15, 2020	BUY	$182.24 - $241.7 $95,676 - $126,892	525 Added 55.03%	1,479 $300,000
Q4 2019 Jan 14, 2020	BUY	$189.21 - $243.2 $180,506 - $232,012	954 New	954 $230,000
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $1.7 Million - $2.04 Million	-9,762 Closed	0 $0
Q2 2019 Jul 09, 2019	BUY	$166.7 - $195.41 $25,005 - $29,311	150 Added 1.56%	9,762 $1.8 Million
Q1 2019 Apr 03, 2019	BUY	$180.87 - $203.88 $262,261 - $295,626	1,450 Added 17.77%	9,612 $1.83 Million
Q4 2018 Jan 11, 2019	BUY	$178.4 - $208.25 $465,624 - $543,532	2,610 Added 47.01%	8,162 $1.59 Million
Q3 2018 Oct 03, 2018	BUY	$185.29 - $208.89 $148,232 - $167,112	800 Added 16.84%	5,552 $1.15 Million
Q2 2018 Jul 05, 2018	SELL	$166.05 - $186.51 $87,176 - $97,917	-525 Reduced 9.95%	4,752 $877,000
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $59,300 - $69,300	-350 Reduced 6.22%	5,277 $900,000
Q4 2017 Jan 09, 2018	BUY	$168.79 - $188.59 $392,436 - $438,471	2,325 Added 70.41%	5,627 $979,000
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $552,391 - $630,682	3,302	3,302 $616,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Account

New England Research & Management, Inc. Amgen Inc Transaction History